Bacterial type VI secretion system (T6SS): an evolved molecular weapon with diverse functionality.
- Published in:
- Biotechnology Letters, 2023, v. 45, n. 3, p. 309, doi. 10.1007/s10529-023-03354-2
- By:
- Publication type:
- Article
Works matching IS 01415492 AND DT 2023 AND VI 45 AND IP 3
Results: 9
1
2
Establishment of a visual gene knockout system based on CRISPR/Cas9 for the rare actinomycete Nonomuraea gerenzanensis.
- Published in:
- Biotechnology Letters, 2023, v. 45, n. 3, p. 401, doi. 10.1007/s10529-023-03347-1
- By:
- Publication type:
- Article
3
Enzymatic approaches against SARS-CoV-2 infection with an emphasis on the telomere-associated enzymes.
- Published in:
- Biotechnology Letters, 2023, v. 45, n. 3, p. 333, doi. 10.1007/s10529-023-03352-4
- By:
- Publication type:
- Article
4
Establishment and characterization of immortalized human vocal fold fibroblast cell lines.
- Published in:
- Biotechnology Letters, 2023, v. 45, n. 3, p. 347, doi. 10.1007/s10529-023-03350-6
- By:
- Publication type:
- Article
5
Long term culturing of CHO cells: phenotypic drift and quality attributes of the expressed monoclonal antibody.
- Published in:
- Biotechnology Letters, 2023, v. 45, n. 3, p. 357, doi. 10.1007/s10529-023-03346-2
- By:
- Publication type:
- Article
6
Retraction Note: miR-34a attenuates glioma cells progression and chemoresistance via targeting PD-L1.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
7
Cellulase and chitinase activities and antagonism against Fusarium oxysporum f.sp. cubense race 1 of six Trichoderma strains isolated from Mexican maize cropping.
- Published in:
- Biotechnology Letters, 2023, v. 45, n. 3, p. 387, doi. 10.1007/s10529-022-03343-x
- By:
- Publication type:
- Article
8
Therapeutic potential of a novel IP-10-(anti-HER2 scFv) fusion protein for the treatment of HER2-positive breast cancer.
- Published in:
- Biotechnology Letters, 2023, v. 45, n. 3, p. 371, doi. 10.1007/s10529-022-03342-y
- By:
- Publication type:
- Article
9
CD44 mediates hyaluronan to promote the differentiation of human amniotic mesenchymal stem cells into chondrocytes.
- Published in:
- Biotechnology Letters, 2023, v. 45, n. 3, p. 411, doi. 10.1007/s10529-022-03322-2
- By:
- Publication type:
- Article